{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:07:38Z","timestamp":1790352458703,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T00:00:00Z","timestamp":1604620800000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004032","name":"Parkinson Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004032","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.heliyon.2020.e05472","type":"journal-article","created":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T08:20:15Z","timestamp":1605514815000},"page":"e05472","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Desipramine, commonly used as a noradrenergic neuroprotectant in 6-OHDA-lesions, leads to local functional changes in the urinary bladder and gastrointestinal tract in healthy rats"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0230-3008","authenticated-orcid":false,"given":"Maria del Pilar","family":"Murillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrik","family":"Aronsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2527-4713","authenticated-orcid":false,"given":"Michael","family":"Winder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3632-8959","authenticated-orcid":false,"given":"Thomas","family":"Carlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2020.e05472_bib1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bbr.2018.05.004","article-title":"Beneficial effect of etazolate on depression-like behavior and, learning, and memory impairment in a model of Parkinson's disease","volume":"350","author":"Alzoubi","year":"2018","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.heliyon.2020.e05472_bib2","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000111144","article-title":"Desipramine induces apoptotic cell death through nonmitochondrial and mitochondrial pathways in different types of human colon carcinoma cells","volume":"81","author":"Arimochi","year":"2008","journal-title":"Pharmacology"},{"key":"10.1016\/j.heliyon.2020.e05472_bib3","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1476-5381.1970.tb10655.x","article-title":"Time course of the effects of 6-hydroxydopamine on catecholamine-containing neurones in rat hypothalamus and striatum","volume":"40","author":"Bell","year":"1970","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2020.e05472_bib4","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF00492213","article-title":"The in vivo distribution of an antidepressant drug (DMI) in male and female rats","volume":"65","author":"Biegon","year":"1979","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.heliyon.2020.e05472_bib5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neulet.2009.10.035","article-title":"Functional and neurochemical changes of the gastrointestinal tract in a rodent model of Parkinson's disease","volume":"467","author":"Blandini","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.heliyon.2020.e05472_bib6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.tox.2008.05.010","article-title":"Desipramine-induced apoptosis in human PC3 prostate cancer cells: activation of JNK kinase and caspase-3 pathways and a protective role of [Ca2+]i elevation","volume":"250","author":"Chang","year":"2008","journal-title":"Toxicology"},{"key":"10.1016\/j.heliyon.2020.e05472_bib7","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.autneu.2012.04.005","article-title":"Intestinal dysmotility and enteric neurochemical changes in a Parkinson's disease rat model","volume":"169","author":"Colucci","year":"2012","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.heliyon.2020.e05472_bib8","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/hipo.22835","article-title":"Modelling the dopamine and noradrenergic cell loss that occurs in Parkinson's disease and the impact on hippocampal neurogenesis","volume":"28","author":"Ermine","year":"2018","journal-title":"Hippocampus"},{"key":"10.1016\/j.heliyon.2020.e05472_bib9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s002109900045","article-title":"Activation and desensitization by cyclic antidepressant drugs of alpha2-autoreceptors, alpha2-heteroreceptors and 5-HT1A-autoreceptors regulating monamine synthesis in the rat brain in vivo","volume":"360","author":"Esteban","year":"1999","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.heliyon.2020.e05472_bib11","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1124\/jpet.115.228510","article-title":"Enteric dysfunctions in experimental Parkinson's disease: alterations of excitatory cholinergic neurotransmission regulating colonic motility in rats","volume":"356","author":"Fornai","year":"2016","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.heliyon.2020.e05472_bib12","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.cellsig.2004.11.005","article-title":"Effect of desipramine on Ca2+ levels and growth in renal tubular cells","volume":"17","author":"Ho","year":"2005","journal-title":"Cell. Signal."},{"key":"10.1016\/j.heliyon.2020.e05472_bib13","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1006\/exnr.1998.6848","article-title":"Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat","volume":"152","author":"Kirik","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.heliyon.2020.e05472_bib14","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s12640-019-00145-4","article-title":"p-Chloroamphetamine-Enhanced neostriatal dopamine exocytosis in rats neonatally Co-lesioned with 6-OHDA and 5,7-DHT: relevance to Parkinson's disease","volume":"37","author":"Kostrzewa","year":"2020","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.heliyon.2020.e05472_bib15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jneumeth.2007.02.015","article-title":"Appropriate dosing regimens for treating juvenile rats with desipramine for neuropharmacological and behavioral studies","volume":"163","author":"Kozisek","year":"2007","journal-title":"J.\u00a0Neurosci. Methods"},{"key":"10.1016\/j.heliyon.2020.e05472_bib16","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1111\/nmo.12691","article-title":"Response of colonic motility to dopaminergic stimulation is subverted in rats with nigrostriatal lesion: relevance to gastrointestinal dysfunctions in Parkinson's disease","volume":"27","author":"Levandis","year":"2015","journal-title":"Neuro Gastroenterol. Motil."},{"key":"10.1016\/j.heliyon.2020.e05472_bib17","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.expneurol.2013.11.015","article-title":"The effect of additional noradrenergic and serotonergic depletion on a lateralised choice reaction time task in rats with nigral 6-OHDA lesions","volume":"253","author":"Lindgren","year":"2014","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.heliyon.2020.e05472_bib18","series-title":"Desipramine. StatPearls: Treasure Island (FL)","author":"Maan","year":"2020"},{"key":"10.1016\/j.heliyon.2020.e05472_bib19","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/0960327110361751","article-title":"Chromosomal aberrations induced by imipramine and desipramine in mouse","volume":"29","author":"Madrigal-Bujaidar","year":"2010","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.heliyon.2020.e05472_bib20","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/BF00173019","article-title":"Effect of desipramine-induced blockade of neuronal uptake mechanisms on adrenoceptor-mediated responses in the Guinea-pig colon","volume":"350","author":"Marino","year":"1994","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.heliyon.2020.e05472_bib21","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1038\/sj.bjp.0704196","article-title":"Acute and chronic effects of desipramine and clorgyline on alpha(2)-adrenoceptors regulating noradrenergic transmission in the rat brain: a dual-probe microdialysis study","volume":"133","author":"Mateo","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2020.e05472_bib22","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3233\/JPD-140509","article-title":"Local change in urinary bladder contractility following CNS dopamine denervation in the 6-OHDA rat model of Parkinson's disease","volume":"5","author":"Mitra","year":"2015","journal-title":"J.\u00a0Parkinsons Dis."},{"key":"10.1016\/j.heliyon.2020.e05472_bib23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF00510547","article-title":"Plasma levels of imipramine and desipramine in man after different routes of administration","volume":"290","author":"Nagy","year":"1975","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.heliyon.2020.e05472_bib24","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/1440-1681.13072","article-title":"Evaluation of the potentiating effects of antidepressants on the contractile response to noradrenaline in Guinea pig urethra smooth muscles","volume":"46","author":"Obara","year":"2019","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.heliyon.2020.e05472_bib25","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0022-3565(24)37161-7","article-title":"Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites","volume":"283","author":"Owens","year":"1997","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.heliyon.2020.e05472_bib26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neuropharm.2017.05.016","article-title":"Effects of L-DOPA\/benserazide co-treatment on colonic excitatory cholinergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration","volume":"123","author":"Pellegrini","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.heliyon.2020.e05472_bib27","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12974-016-0608-5","article-title":"Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration","volume":"13","author":"Pellegrini","year":"2016","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.heliyon.2020.e05472_bib28","doi-asserted-by":"crossref","first-page":"104821","DOI":"10.1016\/j.nbd.2020.104821","article-title":"Pathological remodelling of colonic wall following dopaminergic nigrostriatal neurodegeneration","volume":"139","author":"Pellegrini","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.heliyon.2020.e05472_bib29","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF01250009","article-title":"Catecholamines and serotonin in the rat central nervous system after 6-OHDA, 5-7-DHT and p-CPA","volume":"59","author":"Reader","year":"1984","journal-title":"J.\u00a0Neural. Transm."},{"key":"10.1016\/j.heliyon.2020.e05472_bib30","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/0024-3205(87)90093-2","article-title":"A\u00a0comparative study of the affinities of some tricyclic antidepressants for the muscarinic cholinergic receptor in human and Guinea-pig bladder, ileum and brain in relation to differential drug potency","volume":"40","author":"Rehavi","year":"1987","journal-title":"Life Sci."},{"key":"10.1016\/j.heliyon.2020.e05472_bib31","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1007\/s00213-014-3510-9","article-title":"Influence of acute or chronic administration of ovarian hormones on the effects of desipramine in the forced swim test in female rats","volume":"231","author":"Shah","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.heliyon.2020.e05472_bib32","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s12012-017-9435-x","article-title":"Inhibition of the voltage-dependent K(+) current by the tricyclic antidepressant desipramine in rabbit coronary arterial smooth muscle cells","volume":"18","author":"Shin","year":"2018","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.heliyon.2020.e05472_bib33","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/nau.20917","article-title":"Development of bladder dysfunction in a rat model of dopaminergic brain lesion","volume":"30","author":"Soler","year":"2011","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.heliyon.2020.e05472_bib34","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/0006-8993(91)90669-M","article-title":"Suppression of noradrenergic innervation compensates for behavioral deficits induced by lesion of dopaminergic terminals in the lateral septum","volume":"552","author":"Taghzouti","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.heliyon.2020.e05472_bib35","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1536\/ihj.25.397","article-title":"Augmented central cholinergic mechanisms in spontaneously hypertensive rats. Involvement of deranged noradrenergic mechanisms in the brain","volume":"25","author":"Takahashi","year":"1984","journal-title":"Jpn. Heart J."},{"key":"10.1016\/j.heliyon.2020.e05472_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(95)00221-6","article-title":"In vivo and in vitro effects of muscarinic receptor antagonists on contractions and release of [3H]acetylcholine in the rabbit urinary bladder","volume":"281","author":"Tobin","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2020.e05472_bib37","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0014-2999(68)90164-7","article-title":"6-Hydroxy-dopamine induced degeneration of central monoamine neurons","volume":"5","author":"Ungerstedt","year":"1968","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2020.e05472_bib38","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/sj.bjp.0705388","article-title":"Dopaminergic mechanisms underlying bladder hyperactivity in rats with a unilateral 6-hydroxydopamine (6-OHDA) lesion of the nigrostriatal pathway","volume":"139","author":"Yoshimura","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2020.e05472_bib39","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.physbeh.2007.05.033","article-title":"Changes on 5-HT2 receptor mRNAs in striatum and subthalamic nucleus in Parkinson's disease model","volume":"92","author":"Zhang","year":"2007","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.heliyon.2020.e05472_bib40","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.trsl.2015.02.003","article-title":"Alteration of enteric monoamines with monoamine receptors and colonic dysmotility in 6-hydroxydopamine-induced Parkinson's disease rats","volume":"166","author":"Zhang","year":"2015","journal-title":"Transl. Res."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402032315X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402032315X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:43:36Z","timestamp":1790351016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240584402032315X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S240584402032315X"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2020.e05472","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Desipramine, commonly used as a noradrenergic neuroprotectant in 6-OHDA-lesions, leads to local functional changes in the urinary bladder and gastrointestinal tract in healthy rats","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2020.e05472","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e05472"}}